Market Tracker

09/17 6:02pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

8.48
Data as of Sep 17
 -1.17 / -12.12%
Today’s Change
7.38
Today|||52-Week Range
10.26
+0.47%
Year-to-Date

Today’s Trading

Previous close9.65
Today’s open9.23
Day’s range8.42 - 9.40
Volume10,901,197
Average volume (3 months)2,524,030
Market cap$1.6B
Dividend yield7.08%
Data as of 3:59pm ET, 09/17/2014

Growth & Valuation

Earnings growth (last year)+14.48%
Earnings growth (this year)+28.92%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+18.26%
P/E ratio5.0
Price/Sales2.66
Price/Book11.90

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc+1.97+4.47%
LCILannett Company Inc+0.02+0.05%
MDCOMedicines Co-0.09-0.35%
RCPTReceptos Inc+1.77+2.89%
Data as of 4:01pm ET, 09/17/2014

Financials

Next reporting dateNovember 12, 2014
EPS forecast (this quarter)$0.58
Annual revenue (last year)$442.9M
Annual profit (last year)$264.5M
Net profit margin59.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts